iDtheinvestordatabase
Home / Directory / Signet Healthcare Partners
Likely active: portfolio news May 2025 Verified 5 Nov 2026

Signet Healthcare Partners

New York, NY growth capital investor in commercial-stage or near-launch healthcare companies, mainly in pharmaceuticals and medical devices, reporting over $600 million raised and 55+ companies backed.

Type
VC firm
Location
New York, New York, United States
Stages
Growth
Backs
Biotech and pharma
Sectors
Industrial, Biotech, Devtools, Healthtech and life sciences, Medtech
Fund size / AUM
$300M Signet Healthcare Partners QP Partnership V (Form D offering, 2022); $239.2M gross private fund assets (Form ADV; private funds: 7, of which venture capital: 7)
Latest fund or filing
15 Apr 2024
Portfolio mix
Biotech and pharma 77%; B2B software 9%; Medtech and digital health 9%; Hardware 6% (n=29, 2011 to 2026)

Contacts on file

For Signet Healthcare Partners, the paid file holds: 8 named decision-makers with roles.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

Primrose BioRK PharmaChr. Olesen Synthesis

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 30 lists